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Background:  Accumulation of tissue advanced glycation end products (AGEs) has been reported as a marker of cumulative glycemic and/
or oxidative stress. It is reported that patients involved with coronary artery disease (CAD) with higher AGEs show worse clinical outcome. 
The aim of this study is to evaluate association between skin autofluorescence (SAF), a non-invasive measure of the accumulation for 
AGEs level of skin, and coronary artery stenosis progression (CASP) of patients underwent percutaneous coronary intervention (PCI). 
methods:  October 2013 to March 2014, 313 patients who underwent PCI and follow-up CAG were enrolled in this study. CASP was 
defined as if there is at least one lesion stenosis greater equal than or equal to 50% at follow-up, which is less than 50% at PCI.
results:  Of the 313 patients, 44 (14.1%) patients showed CASP. respectively. In univariate logistic regression, there was significant 
difference between CASP and non-CASP group regarding SAF (odds ratio [OR]: 3.41; 95% confidence interval [CI]: 1.95 to 5.95; p = 
0.0001), DM (odds ratio [OR]: 1.96; 95% confidence interval [CI]: 1.03 to 3.73; p = 0.0396) and Hemodialysis (odds ratio [OR]: 7.08; 95% 
confidence interval [CI]: 2.35 to 21.3; p = 0.0005). In multivariate logistic regression analysis, SAF (odds ratio [OR]: 3.596; 95% confidence 
interval [CI]: 1.67 to 7.76; p = 0.0011) was considered to be the independent predictors of CASP. When we use the response variable 
greater equal to 2.6 to determine CASP, sensitivity is 0.705 (0.548, 0.832) and specificity is 0.740 (0.683, 0.791).
Conclusion:  SAF showed the possibility as a surrogate marker for CASP, which might explain the worse clinical outcome of CAD patients 
with higher SAF.
